Safety and clinical efficacy of the secretome of stressed peripheral blood mononuclear cells in patients with diabetic foot ulcer-study protocol of the randomized, placebo-controlled, double-blind, multicenter, international phase II clinical trial MARSYAS II.
Alfred GugerellGhazaleh Gouya-LechnerHelmut HofbauerMaria LaggnerFranz TrautingerGabriele AlmerAnja Peterbauer-ScherbMarcus SeiboldWolfram HoetzeneckerChristiane DreschlMichael MildnerHendrik Jan AnkersmitPublished in: Trials (2021)
"A randomized, placebo-controlled, double-blind study to evaluate safety and dose-dependent clinical efficacy of APO-2 at three different doses in patients with diabetic foot ulcer (MARSYAS II)".